1. Home
  2. RBBN vs CMPX Comparison

RBBN vs CMPX Comparison

Compare RBBN & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$2.89

Market Cap

671.1M

Sector

Technology

ML Signal

HOLD

Logo Compass Therapeutics Inc.

CMPX

Compass Therapeutics Inc.

HOLD

Current Price

$4.99

Market Cap

752.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBBN
CMPX
Founded
1997
2014
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
671.1M
752.4M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
RBBN
CMPX
Price
$2.89
$4.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
10
Target Price
$6.00
$13.44
AVG Volume (30 Days)
700.0K
1.8M
Earning Date
10-22-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$868,592,000.00
N/A
Revenue This Year
$5.02
N/A
Revenue Next Year
$5.74
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.38
N/A
52 Week Low
$2.72
$1.33
52 Week High
$5.38
$5.86

Technical Indicators

Market Signals
Indicator
RBBN
CMPX
Relative Strength Index (RSI) 43.66 49.43
Support Level $2.86 $4.83
Resistance Level $3.00 $5.32
Average True Range (ATR) 0.10 0.31
MACD 0.02 -0.09
Stochastic Oscillator 48.44 16.76

Price Performance

Historical Comparison
RBBN
CMPX

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.

Share on Social Networks: